Artificial intelligence (AI) software developer Zebra Medical Vision has announced it will receive funding from the U.K. National Health Service (NHS) to support further development of AI-enabled programs for osteoporosis prevention.
Zebra is collaborating with NHS Greater Glasgow & Clyde in Scotland to develop AI-enabled software for vertebral fracture screening in osteoporosis prevention services. The collaboration seeks to establish evidence on how AI-enabled programs impact patient outcomes.
The NHS is providing 140 million pounds (163 million euros) over four years for efforts to accelerate the testing and evaluation of AI technologies that meet the aims set out in its NHS Long Term Plan.
![A normal mammogram confirmed by three-year radiologic follow-up illustrates reader-marked regions of interest (ROIs) during (A) unaided (round 1) and (B) artificial intelligence (AI)–assisted (round 2) reading. Each colored dot represents an ROI for recall by a human reader. Readers could mark more than one ROI per case, represented by multiple dots of the same color. During AI-assisted reading, the AI system displayed three visible prompts: two with suspicion of malignancy scores of 35% (left mediolateral oblique [L MLO] and craniocaudal [L CC]) and one with a suspicion of malignancy score of 10% (right craniocaudal [R CC]), shown as polygonal overlays. Without AI, six of 10 readers (60%) marked a false-positive ROI. With AI assistance, this fell to two of 10 (20%). R MLO = right mediolateral oblique.](https://img.auntminnieeurope.com/mindful/smg/workspaces/default/uploads/2026/07/2026-07-14-radiology-mammogram-ai-auto-bias.H0bYO8QlWs.jpg?auto=format%2Ccompress&dpr=2&fit=crop&h=167&q=70&w=250)
